Britain’s GSK gets EMA clearance for drug to prevent HIV
HQ Team July 24, 2023: British pharmaceutical firm, GSK Plc., has got marketing authorization from the European Medicines Authority for its injectable, and
HQ Team July 24, 2023: British pharmaceutical firm, GSK Plc., has got marketing authorization from the European Medicines Authority for its injectable, and
HQ Team July 24, 2023: The reliance of countries on external support for funding initiatives to combat HIV is worrisome, and though new
HQ Team July 21, 2023: Emergent BioSolutions Inc., a US developer of vaccines for infectious diseases, announced its anthrax vaccine has been approved
HQ Team July 24, 2023: US-based Verrica Pharmaceuticals, a dermatology therapeutics company, has got FDA approval for a drug to treat a contagious
HQ Team July 22, 2023: Urinary tract infections (UTIs) affect nearly one in two women at least once in their lifetime. The growing
HQ Team July 20, 2023: The WHO has sounded a global alert on a batch of substandard cough syrup found in Cameroon, which
HQ Team July 19, 2023: Researchers from Indiana University have made a significant breakthrough in understanding the genetic factors behind Alcohol Use Disorders
HQ Team July 19, 2023: As the global climate continues to change, the impact of rising temperatures is becoming increasingly evident, not only
HQ Team July 18, 2023: Eli Lilly’s Alzheimer’s experimental drug, donanedab, slowed down cognitive and functional decline in people with early symptoms of